Internal restructuring
Location of affected unit(s)
Gidy, Orléans, Croissy, Suresnes
Professional Services
Scientific, Architectural And Engineering Technical Activities
Scientific Research And Development
72 - Scientific research and development

100 - 287 jobs
Number of planned job losses
Job loss
Announcement Date
28 September 2020
Employment effect (start)
1 April 2021
Foreseen end date


The management of the pharmaceutical laboratory Servier has announced the 287 job cuts in its Research and Development (R&D) by 2021,that is slightly less than 20% of its R&D workforce in France. The departures will be on a voluntary basis, through a 'rupture conventionnelle collective', which leaves a small margin of uncertainty on the number of departures. The company confirmed the reorganisation but not the numbers involved and that negotiations will start in November.

According to the union, the departures would concern the entities of Biologie Servier at the Gidy (Loiret) site of Technologie Servier at Orléans (Loiret) and the Servier Research Institute at Croissy (Yvelines) and Suresnes (Haut-de-Seine) plants, as well as the Servier International Research Institute, also based in Suresnes. The group has indicated that it wishes to regroup its activities at its future site in Saclay (Essonnes) as it is turning towards oncology, neurology and immuno-inflammation. It will undoubtedly create jobs in these fields and will cease its research activities in cardiology and metabolic diseases. 

The group employs 4,800 people in France. A former reorganisation was recorded in 2015, with 610 job cuts at Gidy.



Eurofound (2020), Les Laboratoires Servier, Internal restructuring in France, factsheet number 101949, European Restructuring Monitor. Dublin, https://restructuringeventsprod.azurewebsites.net/restructuring-events/detail/101949.